OXER1 and breast carcinoma: In agreement, inhibition of 5-oxo-ETE production by blocking 12-LOX and 5-LOX results in reduced proliferation and induced cytotoxicity and apoptosis, further supporting OXER1 role in breast cancer [36,37].